amiodarone has been researched along with voriconazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sebestyén, Z; Szabó, B; Szepesi, K | 1 |
| Johnson, MD; Mourad, A; Perfect, JR; Stiber, JA | 1 |
| Bocci, G; Ciofi, L; Cucchiara, F; Danesi, R; Di Paolo, A; Lastella, M; Luci, G; Muscatello, B; Paolilli, O; Pellegrini, G; Pisaturo, F; Sarli, V | 1 |
| Bahrami, S; Bemani, E; Oryan, A | 1 |
| Duan, Z; Li, M; Liu, Y; Tong, J; Zeng, R; Zheng, N | 1 |
2 review(s) available for amiodarone and voriconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole | 2013 |
9 other study(ies) available for amiodarone and voriconazole
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Real-world implications of QT prolongation in patients receiving voriconazole and amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antifungal Agents; Drug Interactions; Female; Humans; Long QT Syndrome; Male; Middle Aged; Retrospective Studies; Voriconazole | 2019 |
Appropriateness of repetitive therapeutic drug monitoring and laboratory turnaround time.
Topics: Amiodarone; Daptomycin; Drug Monitoring; Humans; Laboratories, Hospital; Levetiracetam; Time Factors; Voriconazole | 2019 |
Efficacy of amiodarone and voriconazole combination therapy in cutaneous leishmaniasis in the mice experimentally infected with Leishmania major.
Topics: Amiodarone; Animals; Antiprotozoal Agents; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Voriconazole | 2021 |
Interaction of Amiodarone with Azoles Against Aspergillus Planktonic Cells and Biofilms in vitro.
Topics: Amiodarone; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Biofilms; Itraconazole; Microbial Sensitivity Tests; Plankton; Voriconazole | 2022 |